Anixa Biosciences Inc

NASDAQ:ANIXUnited States

Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs include the development of a preventative vaccine against triple negative breast cancer (TNBC), the most lethal form of breast cancer, as well as other forms of breast cancer and the development of a preventative vaccine against ovarian cancer. Its therapeutics programs include the development of a chimeric endocrine receptor T cell therapy, a novel form of chimeric antigen receptor T cell (CAR-T) technology, initially focused on treating ovarian cancer, which is being developed by its subsidiary, Certainty Therapeutics, Inc. (Certainty). Certainty is developing immuno-therapy drugs against cancer. The Company’s vaccine portfolio consists of technology focused on the immunization against specific retired proteins.

Contact Information

Headquarters

3150 Almaden Expy Ste 250SAN JOSE, CA, United States 95118

Phone

408-708-9808

Fax

302-655-5049

Executives

Chairman of the Board, Chief Executive Officer

Amit Kumar

President, Chief Financial Officer, Chief Operating Officer, Company Secretary

Michael Catelani

Lead Independent Director

Lewis Titterton

Independent Director

Arnold Baskies

Independent Director

Emily Gottschalk